Multidrug-resistant acinetobacter baumanii clinical isolates and in vitro evaluation of tigecycline

ABSTRACT

Background: Infections by multidrug-resistant [MDR] and pan-resistant A.baumanii have become a challenging problem. Resistance to carbapenems is a rising problem. Tigecycline provided a new hope for the treatment of MDR- A. baumannii infections. Our aim was to assess the incidence of MDRA. baumanii in various nosocomial infections in our institution, detecting the carbapenemase activity in those strains and finally in vitro evaluation of tigecycline against sensitive and MDR-A.baumanii strains